IP Library Assignment 074849/0404
Patent Assignment
Reel/Frame 074849/0404

Grant of Security Interest

Recorded: 2026-02-18 Pages: 7
Assignor
EAGLE BIOLOGICS, INC.
Executed: 2026-02-03
Assignee
ANKURA TRUST COMPANY, LLC
140 SHERMAN STREET, 4TH FLOOR, FAIRFIELD, CONNECTICUT, 06824
Covered Properties (14)
Liquid Protein Formulations Containing Viscosity-Lowering Agents
Application: 17/101,063 →
Publication: US 2021/0085792
Liquid Protein Formulations Containing Viscosity-Lowering Agents
Application: 18/438,199 →
Publication: US 2024/0181063
Liquid Protein Formulations Containing Ionic Liquids
Application: 18/635,538 →
Publication: US 2024/0285766
Liquid Protein Formulations for Injection Comprising 1-Butyl-3-Methylimidazolium Methanesulfonate and Uses Thereof
Patent: 9,833,513 →
Application: 14/484,053 →
Publication: US 2015/0071922
Liquid Pharmaceutical Formulations for Injection Comprising Thiamine Pyrophosphate 1-(3-Aminopropyl)-2-Methyl-1H-Imidazole and Uses Thereof
Patent: 9,913,905 →
Application: 14/483,896 →
Publication: US 2015/0071921
Liquid Pharmaceutical Formulations for Injection Comprising Procaine and Uses Thereof
Patent: 9,925,263 →
Application: 14/484,160 →
Publication: US 2015/0071925
Liquid Pharmaceutical Formulations for Injection Comprising Yellow 5 or Orange G and Uses Thereof
Application: 14/483,880 →
Publication: US 2015/0071920
Liquid Protein Formulations Containing Cimetidine
Application: 15/903,523 →
Publication: US 2018/0177875
Liquid Protein Formulations Containing 4-(3-Butyl-1-Imidazolio)-1-Butane Sulfonate (Bim)
Application: 15/809,602 →
Publication: US 2018/0085463
Liquid Protein Formulations Containing Thiamine Pyrophosphate (Tpp)
Application: 15/890,044 →
Publication: US 2018/0153997
Liquid Protein Formulations Containing Thiamine
Application: 15/903,635 →
Publication: US 2018/0177876
Polysaccharide and Nucleic Acid Formulations Containing Viscosity-Lowering Agents
Application: 15/516,074 →
Publication: US 2018/0228831
Liquid Protein Formulations Containing Cyclic Adenosine Monophosphate (Camp) or Adenosine Triphosphate (Atp)
Application: 17/067,058 →
Publication: US 2021/0038718
Liquid Protein Formulations Containing 4-Ethyl-4-Methylmorpholinium Methylcarbonate (Emmc)
Application: 17/073,618 →
Publication: US 2021/0030877
Related Assignments (15)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 5, 2014
From: LARSON, ALYSSA M.; LOVE, KEVIN; WEIGHT, ALISHA K.; CRANE, ALAN
To: ARSIA THERAPEUTICS, INC.
Reel/Frame 034109/0272 →
Assignment of Assignor's Interest Nov 5, 2014
From: LARSON, ALYSSA M.; LOVE, KEVIN; WEIGHT, ALISHA K.; CRANE, ALAN
To: ARSIA THERAPEUTICS, INC.
Reel/Frame 034108/0123 →
Assignment of Assignor's Interest Nov 5, 2014
From: LARSON, ALYSSA M.; LOVE, KEVIN; WEIGHT, ALISHA K.; CRANE, ALAN
To: ARSIA THERAPEUTICS, INC.
Reel/Frame 034108/0670 →
Assignment of Assignor's Interest Nov 5, 2014
From: LARSON, ALYSSA M.; LOVE, KEVIN; WEIGHT, ALISHA K.; CRANE, ALAN
To: ARSIA THERAPEUTICS, INC.
Reel/Frame 034109/0701 →
Security Interest Jan 26, 2017
From: ARSIA THERAPEUTICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 041095/0720 →
Change of Name Mar 24, 2017
From: ARSIA THERAPEUTICS, INC.
To: EAGLE BIOLOGICS, INC.
Reel/Frame 042091/0043 →
Assignment of Assignor's Interest Mar 31, 2017
From: LARSON, ALYSSA M.; LOVE, KEVIN; WEIGHT, ALISHA K.; CRANE, ALAN
To: ARSIA THERAPEUTICS, INC.
Reel/Frame 041805/0794 →
Assignment of Assignor's Interest Mar 31, 2017
From: LARSON, ALYSSA M.; LOVE, KEVIN; WEIGHT, ALISHA K.; CRANE, ALANE
To: ARSIA THERAPEUTICS, INC.
Reel/Frame 041805/0507 →
Assignment of Assignor's Interest Mar 31, 2017
From: LARSON, ALYSSA M.; LOVE, KEVIN; WEIGHT, ALISHA K.; CRANE, ALAN
To: ARSIA THERAPEUTICS, INC.
Reel/Frame 041805/0603 →
Assignment of Assignor's Interest Mar 31, 2017
From: LARSON, ALYSSA M.; LOVE, KEVIN; WEIGHT, ALISHA K.; CRANE, ALAN
To: ARSIA THERAPEUTICS, INC.
Reel/Frame 041806/0230 →
Change of Name Mar 31, 2017
From: ARSIA THERAPEUTICS, INC.
To: EAGLE BIOLOGICS, INC.
Reel/Frame 042126/0564 →
Security Interest Oct 24, 2022
From: EAGLE BIOLOGICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 061513/0703 →
Security Interest Nov 1, 2022
From: EAGLE BIOLOGICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 061614/0716 →
Security Interest Oct 11, 2024
From: EAGLE BIOLOGICS, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 068873/0905 →
Release of Security Interest Apr 1, 2025
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: EAGLE BIOLOGICS, INC.
Reel/Frame 070698/0881 →